Autori: Stupp Roger
| Naslov | Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial (Article) |
| Autori | Stupp Roger ... Grujicic Danica M ... (broj koautora 37) |
| Info | LANCET ONCOLOGY, (2014), vol. 15 br. 10, str. 1100-1108 |
| Projekat | Merck KGaA, Darmstadt, Germany |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma and methylated O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter: Key results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study. (Meeting Abstract) |
| Autori | Stupp Roger ... Grujicic Danica M ... (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2013), vol. 31 br. 18, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation: Final results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study. (Meeting Abstract) |
| Autori | Stupp Roger ... Grujicic Danica M ... (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2013), vol. 31 br. 15, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
